Another group found that astrocytes derived from the ventral midbrain (VM) demonstrated the ability to inhibit α-synuclein aggregation and transmission in various in vitro and in vivo models of α-synucleinopathy (Yang et al. 2022b). Here, SNCA is linked to synucleinopathy.